Cleantech Transit, Inc. (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net).

One of the main benefits of biomass fuel over fossil fuel can be best understood in terms of greenhouse gasses. While both biomass fuels and fossil fuels release about the same amount of carbon dioxide into the atmosphere when burned, there is a distinct difference in the effect they each have on the atmosphere. Burning fossil fuel releases carbon dioxide that was captured during photosynthesis literally millions of years ago. As it is burned, carbon dioxide is released as a new greenhouse gas, a ‘new’ carbon dioxide. Biomass fuel, on the other hand, releases carbon dioxide that was recently captured during photosynthesis and it tends to equal itself out. Nothing ‘new’ is being sent into the atmosphere, thus greatly reducing the greenhouse gas effect on the ozone layer.

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

For more information please visit official website of CLNO: www.cleantechtransit.com

************************

Lannett Company, Inc. (AMEX:LCI) announced the appointment of Jeffrey Farber as Vice Chairman of the Board. Farber, 50, has served as a member of Lannett’s board since May 2006. He founded and is president of Auburn Pharmaceutical, a national generic pharmaceutical distributor. Earlier, Farber held a number of senior management roles in sales and purchasing at Major Pharmaceutical, before becoming its president of the mid-west division. He also served on the board of directors of Vitarine Pharmaceuticals, the manufacturing division of Major Pharmaceutical. Farber earned a bachelor of science degree in business administration from Western Michigan University, and participated in the Pharmacy Management Graduate Program at Long Island University.

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit the company’s website at www.lannett.com.

************************

Dreams Inc. (Amex:DRJ), a technology driven, multi-channel retailer focused on the licensed sports products industry, reported financial results for the second quarter ended June 30, 2011. Total revenues in the second quarter of 2011 increased 30% to $18.6 million, compared to $14.4 million in the same year-ago quarter. This was attributable to a 39% increase in e-commerce revenues to $12.9 million. E-commerce revenues were driven by Dreams’ web syndication platform, which generated a 45% increase in revenues to $4.5 million, and a 36% increase in the company’s owned brands to $8.3 million.

Dreams, Inc., together with its subsidiaries, engages in the manufacturing, distributing, retailing, and selling sports licensed products, memorabilia, and acrylic display cases through various channels, including Internet, brick and mortar, catalogue, kiosks, and trade shows in North America.

************************

Hemispherx Biopharma, Inc. (Amex:HEB) announced its authorized agent GP Pharm Argentina has submitted to the ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica) regulatory agency responsible for the national administration of drugs, foods and medical technology for the approval of Alferon N Injection(R) for sales and distribution in Argentina. In June 2010, Hemispherx agreed to provide GP Pharm an option to market Alferon N Injection(R), its FDA approved natural interferon, in Argentina and other Latin America countries as well. It is planned to be marketed under the brand name Naturaferon(R). Alferon N Injection(R) is approved in the US for the treatment of refractory genital warts and a major scale-up of Alferon N Injection(R) manufacturing is underway at Hemispherx’s New Brunswick, NJ facility.

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

**********************************************

Sign Up for Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit,Inc. (CLNO.OB).


 

 

Flowers Foods, Inc. (NYSE:FLO) reported sales and earnings for its 12 and 28 weeks ended July 16, 2011. Taking into consideration the 3-for-2 stock split that was effective June 24, 2011, highlights of the quarter were: Completion of the acquisition of Tasty Baking Company, adding annualized sales of approximately $200 million. Earnings per share of $.21 compared to $.24, a decrease of 12.5% from the second quarter last year. Excluding one-time charges related to the Tasty acquisition, earnings per share were $.23, a decrease of 4.2%.

Flowers Foods, Inc. produces and markets bakery products in the United States. It operates in two segments, Direct-Store-Delivery (DSD) and Warehouse Delivery.

*******************************************

VoIP (Voice over Internet Protocol) is a technology that allows telephone calls to be made over computer networks like the Internet. VoIP converts analog voice signals into digital data packets and supports real-time, two-way transmission of conversations using Internet Protocol (IP). VoIP calls can be made on the Internet using a VoIP service provider and standard computer audio systems. Alternatively, some service providers support VoIP through ordinary telephones that use special adapters to connect to a home computer network.

Crown Equity Holdings Inc. (OTC:CRWE), together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.

Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

Crown Equity Holdings Inc. is pleased to announce that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.

Commenting on the joint venture, Kenneth Bosket, President of Crown Equity Holdings Inc., said: “We are excited to deliver VoIP communications solutions specifically designed to meet the business and residential market needs in this fast-growing global market.”

For more information, please visit: http://www.crownequityholdings.com or http://crownteleservices.com/

*******************************************

Lannett Company, Inc. (AMEX:LCI) announced the appointment of Jeffrey Farber as Vice Chairman of the Board. Farber, 50, has served as a member of Lannett’s board since May 2006. He founded and is president of Auburn Pharmaceutical, a national generic pharmaceutical distributor. Earlier, Farber held a number of senior management roles in sales and purchasing at Major Pharmaceutical, before becoming its president of the mid-west division. He also served on the board of directors of Vitarine Pharmaceuticals, the manufacturing division of Major Pharmaceutical.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic pharmaceutical products sold under generic chemical names in the United States.

*******************************************

China Shenghuo Pharmaceutical Holdings, Inc. (AMEX:KUN) reported unaudited financial results for the second quarter ended June 30, 2011. Total revenue increased to $10.9 million for the second quarter of 2011, representing 58% year-over-year growth. Gross margin for the second quarter of 2011 increased to $6.9 million, as compared to approximately $4.4 million for the same period of 2010. Net cash provided by operating activities increased to $2.84 million for the six months ended June 30, 2011 from $1.46 million for the same period of 2010.

China Shenghuo Pharmaceutical Holdings, Inc. engages in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement, and cosmetic products in China.

*************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.